Author: admin

Integral Molecular Achieves ISO 9001 Certification for its Virology Critical Reagents Supporting Vaccine Development

Philadelphia– Integral Molecular, a leader in providing essential research tools that enable vaccine development, proudly announces the achievement of ISO 9001 certification for the […]

Antibody Startup Emerges from Stealth: Cell Surface Bio Set to Transform the $10B Antibody Reagent Market

Company debuts catalog of validated, recombinant, specific antibodies against difficult protein targets, providing only the highest quality reagents for life sciences research Philadelphia – […]

Webinar presented by Integral Molecular and Fierce Biotech – Redefining Antibody Specificity Profiling for IND

Thursday, June 6, 2024 8 am PT, 11 am ET, 17:00 CET Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. […]

Integral Molecular Launches Virus Neutralization Assay Services to Drive Antiviral Discovery

Researchers can now access Integral Molecular’s antibody testing expertise alongside its extensive collection of virus-like reagents including reporter viruses, VLPs, and pseudoviruses to acquire […]

Webinar presented by Integral Molecular and The Antibody Society – Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets

Thursday, April 25, 2024 8 am PT, 11 am ET, 17:00 CET View the recording To exploit highly conserved and difficult drug targets, including […]

Integral Molecular Achieves ISO 9001 Certification for its Membrane Proteome Array Service

ISO 9001 certification validates Integral Molecular’s quality processes for its Membrane Proteome Array, reflecting the company’s commitment to quality. Philadelphia – Integral Molecular, a […]

Integral Molecular Enters Into Exclusive Antibody License With Seismic Therapeutic

Philadelphia – Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets, announced today that it has entered into an […]

Integral Molecular Launches TiterSafe™ Influenza Virus-Like Particles for Safe and Convenient Vaccine Testing

Philadelphia – Integral Molecular, a leading provider of reagents for vaccine evaluation, announces the launch of TiterSafe™ influenza virus-like particles, an off-the-shelf virus-alternative for […]

Integral Molecular Unveils Trispecific Molecules Targeting GPRC5D, BCMA, and CD3 for Multiple Myeloma

Philadelphia – Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets will present multispecific molecules targeting GPRC5D, BCMA, and […]